Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets (Q46373126)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets
scientific article

    Statements

    Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit